Skip to main content
. Author manuscript; available in PMC: 2023 Jun 26.
Published in final edited form as: J Hepatol. 2021 May 29;75(2):271–274. doi: 10.1016/j.jhep.2021.05.020

Table 1.

Baseline details of studies.

Standard graphical abstract Three facts and a story
Type
 Original 29 (94%) 21 (91%)
 Review 2 (6%) 3 (9%)

Clinical science 17 (55%) 14 (61%)

Clinical trial 3 (10%) 1 (4%)

Topic
 Non-alcoholic fatty liver disease 2 (6%) 1 (4%)
 Alcohol-related liver disease 0 (0%) 1 (4%)
 Viral hepatitis 5 (16%) 5 (17%)
 Autoimmune hepatitis 0 (0%) 1 (4%)
 Cholestatic liver disease 2 (6%) 0 (0%)
 Cirrhosis management 5 (16%) 3 (13%)
 Liver cancer 7 (23%) 8 (35%)
 Metabolism/signaling 6 (19%) 5 (22%)
 Liver transplant 3 (10%) 0 (0%)